Most of the patent news in the past week has revolved around pharmaceuticals, but we caught a few gems. First, we’ll revisit one of our news pieces from last week, and then we’ll move on to some movement from Microsoft.
Most of the patent news in the past week has revolved around pharmaceuticals, but we caught a few gems. First, we’ll revisit one of our news pieces from last week, and then we’ll move on to some movement from Microsoft.
Wrapping IPVision’s services and products into a neat little package is nearly impossible. Every company comes to us with a different need. The outcome, however, is the same for everyone: more revenue and greater market share.
Shushing the whispers that Apple had reached the end of its innovative streak, the company was granted 54 patents yesterday, June 20. These patents cover a wide range of products, both currently available and possible for the future. The applications for these patents were filed up to three years ago, with all approved and published in one day.
Patenting your inventions and ideas is a smart move. It allows you to capitalize on unexpected trends in your industry and gain exclusive rights to your designs for a set period of time (assuming you stay up-to-date on your patent fees).
Whether your company is currently on top of the world or working its way there, you know there is always a competitor nipping at your heels. You may already know who that competitor is, or there may be a complete unknown preparing to disrupt your market. You could continue running without any idea how close your competitor is to overtaking you, or you could develop competitive intelligence through the use of patent analysis.
No one would ever say that VMWare is struggling. Though purchased twice since its inception—first by EMC and then again by Dell when all of EMC was acquired—the company has always been considered a separate entity and has performed as such. And with billions of dollars in revenue even now, VMWare is still a major player in virtualization.
Innovation, without insight, is essentially impossible. And when you’re in a constantly evolving industry, insight into your competitors’ IP and patents can prove invaluable when you’re trying to innovate within your own company.
Here’s a newsflash: patents are pretty expensive. Because they are granted on a country by country basis, there are different maintenance and filing fees required by each country in which you’re attempting to obtain a patent. A 2003 study from the United States General Accounting Office reported that the lifetime cost for a small company to file and maintain a patent in the United States (and in 9 other major industrial countries) ranged from US$170,000 to US$340,000 in 2002 Dollars. That’s about $220,000 to $440,000 in 2013 Dollars. It’s also important to note that these figures apply to small companies—which usually pay about half the filing fees that large companies pay.
It was a productive meeting, really. The agenda was clear and concise. The presentations were quick and helpful. Everyone thought it went well. Until the CEO said, “What the %$!@?”
Patent citation analysis that makes it simple to explore complex relationships with a visual guide
Copyright 2021 IPVision, Inc. All Rights Reserved.
Privacy Policy | Terms of Use
Website designed and developed by
RainCastle Communications, Inc.